Overview
Prashant Khirsariya practices practicing medicine in Brno, Czech Republic.
His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL) and Chronic B-Cell Leukemia (CBCL).
He is actively involved in clinical research, co-authoring 14 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Prashant Khirsariya
Is Prashant Khirsariya a top-rated expert for Chronic Lymphocytic Leukemia (CLL)?
MediFind is an objective health platform that identifies experts based on real-world data. Prashant Khirsariya is classified as an Experienced expert for Chronic Lymphocytic Leukemia (CLL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Prashant Khirsariya participate in research or clinical trials?
Yes. Prashant Khirsariya has published 14 articles and abstracts on conditions like Chronic Lymphocytic Leukemia (CLL). You can view a list of Prashant Khirsariya's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Chronic B-Cell Leukemia (CBCL)Mr. Khirsariya isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Mr. Khirsariya isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).